It is a pharma public limited company based in New Delhi, Delhi, India, established in 2006.
2006 | New Delhi, Delhi, India | ActiveZeus Drugs Limited, a active public limited company, was established on 31 August 2006 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85121DL2006PLC152815. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Employing 4 professional, Its leadership includes Rajiv Kumar Sharma (Director), Ritu Sharma (Director), Manni Kaushik (Additional Director). Past directors included Rajendra Prasad Sharma, Ritu Sharma, Dharam Pal Singh. It holds ₹8.63 M open charges and ₹6.20 M settled loans. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at E 1576F/ F, Tigri Colony, New Delhi, Delhi, 110062.
U85121DL2006PLC152815
152815
31 August 2006
₹1.50 M
₹1.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Zeus Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Kumar Sharma | Director | 04 Sep 2006 | Current |
| Ritu Sharma | Director | 21 Feb 2024 | Current |
| Manni Kaushik | Additional Director | 24 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Jun 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 31 Jan 2024 | Past |
| Pramod Abcsdd | Director | 29 Mar 2011 | Past |
| Pramod Abcsdd | Director | 21 Aug 2014 | Past |
| Pramod Abcsdd | Director | 25 Aug 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zeus Drugs Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.6% increase. The company also saw a slight improvement in profitability, with a 1.36% increase in profit. The company's net worth moved up by a moderate rise of 4.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Zeus Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,625,000.00
₹6,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2025 | Others | ₹4.50 M | Open |
| 31 Aug 2024 | Others | ₹4.13 M | Open |
| 07 Apr 2014 | Others | ₹4.70 M | Satisfied |
| 18 Sep 2008 | Punjab National Bank | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Zeus Drugs has a workforce of 4 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zeus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeus Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Zeus Drugs Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 4.50 M with Charge ID 101156054 was registered on 04 Sep 2025. was recorded as a recent event.
Manni Kaushik was appointed as a Additional Director was appointed as a Additional Director on 24 Jul 2025 & has been associated with this company since 4 months 13 days . was recorded as a recent event.
The activity Zeus Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
The activity A charge registered on 07 Apr 2014 via Charge ID 10489972 with Others was fully satisfied on 01 Mar 2025. was completed.
Progress on A charge with Others amounted to Rs. 4.13 M with Charge ID 100969309 was registered on 31 Aug 2024. was documented.
The CIN of Zeus Drugs Limited is U85121DL2006PLC152815.
Zeus Drugs Limited is headquartered at E 1576F/ F, Tigri Colony, New Delhi, Delhi, 110062.
Zeus Drugs Limited was incorporated on 31 August 2006.
The current directors of Zeus Drugs Limited are
The primary industry of Zeus Drugs Limited is Trade.
Zeus Drugs Limited is unlisted.
The authorized capital of Zeus Drugs Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Zeus Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX